Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzheng Jiedu Huayu is a Traditional Chinese Medicine (TCM) herbal formula developed by researchers at the Beijing University of Chinese Medicine Dongzhimen Hospital. It is specifically designed for the treatment of senile pneumonia, a condition with high mortality rates in elderly populations. The therapy is based on the TCM principles of strengthening the body's resistance (Fuzheng), clearing heat and detoxifying (Jiedu), and promoting blood circulation to resolve stasis (Huayu). It is typically administered as an oral decoction and is intended to modulate the inflammatory response, support immune function, and improve microcirculation in patients with respiratory infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuzheng Jiedu Huayu (Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine).